Reuters reports Amgen Inc will buy Celgene Corp’s psoriasis drug Otezla for $13.4 billion in cash. That clears the way for Bristol-Myers Squibb to go ahead with its $74 billion deal for Celgene by..
Credit: Wochit Business Duration: 00:37Published on August 26, 2019
Beyond Meat reported second-quarter earnings Monday. The earning report showed the company lost more money than analysts expected. The plant-based meat alternatives company raised its full-year outlook..
Credit: Wochit News Duration: 00:32Published on July 30, 2019